Raymond B. Ruddy Buys 3,490 Shares of Maximus, Inc. (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMSGet Free Report) Director Raymond B. Ruddy purchased 3,490 shares of the business’s stock in a transaction on Thursday, December 12th. The shares were acquired at an average price of $71.46 per share, with a total value of $249,395.40. Following the purchase, the director now owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Maximus Stock Performance

Shares of NYSE MMS opened at $69.81 on Friday. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The stock has a 50 day moving average of $82.58 and a 200-day moving average of $86.60. Maximus, Inc. has a 12 month low of $69.72 and a 12 month high of $93.97. The company has a market capitalization of $4.21 billion, a P/E ratio of 13.96 and a beta of 0.73.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.72%. Maximus’s dividend payout ratio (DPR) is currently 24.00%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th.

Get Our Latest Research Report on MMS

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of MMS. Assenagon Asset Management S.A. increased its stake in shares of Maximus by 151.6% in the second quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock valued at $19,980,000 after buying an additional 140,481 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Maximus by 942.9% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after acquiring an additional 292,300 shares during the period. SG Americas Securities LLC boosted its position in shares of Maximus by 609.6% during the 2nd quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock worth $1,224,000 after purchasing an additional 12,266 shares in the last quarter. Versor Investments LP grew its stake in Maximus by 213.5% in the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after acquiring an additional 5,789 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Maximus by 12.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock valued at $86,552,000 after purchasing an additional 102,350 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.